Back to Journals » Drug Design, Development and Therapy » A cross-sectional survey on heart failure from China: disease burden and management
Drug Design, Development and Therapy
ISSN: 1177-8881
- View all (3782)
- Volume 17, 2023 (26)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Journal Articles:
- A cross-sectional survey on heart failure from China: disease burden and management (3)
- Ten Years of Biosimilars in Europe (4)
A cross-sectional survey on heart failure from China: disease burden and management
Heart failure (HF) represents a major clinical and public health problem worldwide, affecting 40,000,000 people.1 In China, there are ~4,500,000 individuals with HF. The cross-sectional study described in this Series examines the burden of HF on patients and caregivers, as well as describing the clinical care pathways, management and treatment patterns, and hospitalizations for patients with (HF) in China.


Burden of heart failure on patients from China: results from a cross-sectional survey
Jackson JDS, Cotton SE, Bruce Wirta S, Proenca CC, Zhang M, Lahoz R, Calado FJ
Drug Design, Development and Therapy 2018, 12:1659-1668
Published Date: 8 June 2018


Burden of heart failure on caregivers in China: results from a cross-sectional survey
Jackson JDS, Cotton SE, Bruce Wirta S, Proenca CC, Zhang M, Lahoz R, Calado FJ
Drug Design, Development and Therapy 2018, 12:1669-1678
Published Date: 8 June 2018


Care pathways and treatment patterns for patients with heart failure in China: results from a cross-sectional survey
Jackson JDS, Cotton SE, Bruce Wirta S, Proenca CC, Zhang M, Lahoz R, Balas B, Calado FJ
Drug Design, Development and Therapy 2018, 12:2311-2321
Published Date: 26 July 2018